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ST Elevation Myocardial Infarction - Clinical Outcomes in Rural Southern India
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Background: Cardiovascular disease (CVD) is one of the leading causes of mortality
around the world and in India as well. Atherosclerosis is the underlying cause in most
of the cases. There are several modiﬁable (hypertension, diabetes mellitus, dyslipi-
demia, smoking, tobacco use, obesity and sedentary lifestyle) and non-modiﬁable
(age, gender, family history of premature CVD, race, postmenopausal state)
risk factors. The risk in Indians is around 3 to 4 times higher than in western countries,
also CVD occurs 5 to 10 years earlier in Indians compared to western counterparts.
The prevalence of diabetes mellitus in India is also one of the highest in the world and
diabetes is the major risk factor for development of CVD.
Methods: We analysed the clinical proﬁle and in-hospital outcomes of 400 patients
who presented with acute ST elevation myocardial infarction (STEMI) in a tertiary
care centre in rural southern India.
Results:dMajority of the patients were from the age group 51 to 60 years, followed
by age group 61 to 70 years. MI in the age group 21 to 30 yrs was 3% and above
71 years was 2%.
d Incidence of MI was more in males upto 50 years of age.
d Women predominated men in incidence of MI after 50 years of age.
d Alcohol consumption and smoking were the major risk factors at 40% and
39% respectively, followed by diabetes mellitus at 37% and dyslipidemia at 34%.
d 18% of the patients had no risk factors.
d Smoking, alcohol consumption, systemic hypertension and diabetes were the
major risk factors among males. Diabetes, dyslipidemia and postmenopausal state
were the commonest risk factors among females. 94% of the females were
postmenopausal.
d There were no smokers or alcoholics among females.
d Incidence of diabetes was more in females compared to males, 47% versus 35%.
d Chest pain was the predominant symptom, with 98% of the patients suffering
from it., followed by sweating (45%) and shortness of breath (43%).
d Only 15% of the cases reached the hospital within the golden hour.
d 55% of the cases reached the hospital beyond the golden hour but within 6hrs .
d 14 % of the cases took more than 6 hours to seek medical help.
d Men presented to the hospital earlier than women.,16% versus 10% presented
within the golden hour., 55% of men and 53% of women presented within 1 to 6 hrs.
d Anterior wall myocardial infarction (AWMI) was predominant at 49 % fol-
lowed by Inferior wall myocardial infarction ( IWMI) at 39% .
d 21.56% of IWMI had Right ventricular infarction (RVI)., 2.6 % of IWMI had
posterior wall myocardial infarction (PWMI).
d AWMI predominated among diabetics., 65% versus 51% among non diabetics.
d 4%of cases developed cardiogenic shock, 5%developedVentricular tachycardia
(VT), 3% developed pulmonary oedema, 2% each developed mitral regurgitation
(MR), complete heart block (CHB), and ventricular septal rupture (VSR).
d Complication rates were high among patients with IWMI+RVI: 27% cardio-
genic shock, 18% death and 9% conduction block., none of the patients with pure
IWMI developed cardiogenic shock, however 2.6% developed conduction block.
There was no mortality among patients with pure IWMI.
d Complication rates in AWMI: 8% Shock, 10.7% death7% of AWMI devel-
oped VT compared to 2% of IWMI developed VT.
d Accelerated idioventricular rhythm (AIVR) developed in 6% of patients post
thrombolysis.
d Mortality rate among females was 21% and males was 5%.
d Overall the mortality rate was 8%.
d 82% received thrombolytic therapy. All patients were thrombolysed with
streptokinase. 4.8% of patients developed hypotension during thrombolysis which
was managed with dopamine and dobutamine.
d ST segment elevation reduced more than 50%, 90minutes after thrombolytic
therapy in 72%of patients and ST segment normalized to baseline in 18%of patients.
d Mortality rate in AWMI was 10.7% and IWMI + RVI was 18%.
Conclusion: Mortality rate was higher in patients with IWMI + RVI. Only 15%
reached the hospital within golden hour, more than half of the patients presented
within 6 hours and men sought medical help earlier than women. Outcomes were
favourable when patients received early thrombolytic therapy and those who presented
within the golden hour had better resolution of symptoms and ECG changes post
thrombolysis. Streptokinase is still a good and economical thrombolytic agent.
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Background: Glycoprotein (Gp) IIbIIIa receptor inhibitors are known to reduce mor-
tality, target vessel revascularization but not re-infarction in ST elevation myocardialS38 JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCinfarction (STEMI) patients. We investigated the impact of Gp IIbIIIa receptor
inhibitors on the post procedure TIMI ﬂow and 1 month major clinical outcomes in
diabetic STEMI patients undergoing primary percutaneous coronary intervention (PCI).
Methods: Total of 1562 diabetic STEMI patients undergoing primary PCI with or
without periprocedural Gp IIbIIIa receptor inhibitor coverage were identiﬁed from
Korean AMI registry (KAMIR). Among 1562 patients, 1107 patients didn’t receive
periprocedural GP IIbIIIa receptor inhibitors and 365 patients received.
Results: Baseline characteristics were balanced between the two groups except for
gender and the incidence of ischemic heart disease. There was no signiﬁcant impact of
GPIIbIIIa receptor inhibitor on the post procedure TIMI ﬂow and 1month major
clinical outcomes (Table). Among no Gp IIbIIIa receptor inhibitor usage patients,
80.3% achieved TIMI III ﬂow and 81.6% in the Gp IIbIIIa receptor inhibitor usage.
Conclusion: Although the Gp IIbIIIa receptor inhibitor is known to reduce mortality
and target vessel revascularization in STEMI patients, there was no statistically sig-
niﬁcant impact on the post procedural TIMI ﬂow and 1month major clinical outcomes
in diabetic STEMI patients undergoing primary PCI.TCTAP A-133
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Background: Myocardial infarction (MI) is known to be associated with increased
adverse clinical outcomes in coronary artery diseases. The impact of percutaneous
coronary intervention (PCI) for CTO in patients with myocardial infarction is not
clear. We evaluated the 12-month clinical outcomes between PCI and optimal medical
therapy (OMT) for CTO lesions in MI patients.
Methods: A total of 143 consecutive CTO patients who were admitted for MI
were divided into 2 groups according to treatment strategy; PCI group (n¼68) and OMT
group (n¼75). 12-month clinical outcomes were compared between the two groups.
Results: At baseline, patients in the OMT group showed a higher prevalence of
elderly, hyperlipidemia, peripheral vascular disease, de novo lesion, non-CTO pro-
cedure, multivessel disease, and LCX-CTO. Patients in the PCI group showed a higher
prevalence of prior MI, prior PTCA, and LAD-CTO lesion. Clinical outcomes at 12
months showed lower mortality and lower rates of recurrent MI in the PCI group.
After baseline adjustment by multivariate analysis, however, there was no difference.
Conclusion: At baseline, patients in the OMT group showed a higher prevalence of
elderly, hyperlipidemia, peripheral vascular disease, de novo lesion, non-CTO pro-
cedure, multivessel disease, and LCX-CTO. Patients in the PCI group showed a higher
prevalence of prior MI, prior PTCA, and LAD-CTO lesion. Clinical outcomes at 12
months showed lower mortality and lower rates of recurrent MI in the PCI group.
After baseline adjustment by multivariate analysis, however, there was no difference.TAP Abstracts/POSTER/Acute Coronary Syndrome: STEMI, NSTE-ACS
